<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rakovina Therapeutics Inc — News on 6ix</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc</link>
<description>Latest news and press releases for Rakovina Therapeutics Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 08:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rakovina-therapeutics-inc" rel="self" type="application/rss+xml" />
<item>
<title>Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting</guid>
<pubDate>Wed, 22 Apr 2026 08:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V...</description>
</item>
<item>
<title>Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-at-the-aacr-annual-meeting-2026-worlds-premier-cancer-research-forum</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-at-the-aacr-annual-meeting-2026-worlds-premier-cancer-research-forum</guid>
<pubDate>Mon, 23 Mar 2026 08:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-extension-of-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-extension-of-non-brokered-private-placement</guid>
<pubDate>Thu, 12 Mar 2026 19:28:11 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V...</description>
</item>
<item>
<title>Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-announces-closing-of-dollar1-million-debenture-unit-private-placement-and-debt-settlement-agreements</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-announces-closing-of-dollar1-million-debenture-unit-private-placement-and-debt-settlement-agreements</guid>
<pubDate>Fri, 06 Mar 2026 01:06:59 GMT</pubDate>
<description>VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-upsized-financing-up-to-dollar20-million</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-upsized-financing-up-to-dollar20-million</guid>
<pubDate>Sat, 21 Feb 2026 00:50:01 GMT</pubDate>
<description>Proposed $1.0 Million Convertible Debenture and Warrant Financing and&#xA0; Concurrent Common S...</description>
</item>
<item>
<title>Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-reports-strong-industry-validation-and-emerging-collaborations-following-9th-annual-ddr-inhibitors-summit</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-reports-strong-industry-validation-and-emerging-collaborations-following-9th-annual-ddr-inhibitors-summit</guid>
<pubDate>Wed, 04 Feb 2026 09:00:00 GMT</pubDate>
<description>Highlights: Strategic Validation: Industry feedback confirms Rakovina&#x2019;s approach tar...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-corporate-including-204900771</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-corporate-including-204900771</guid>
<pubDate>Tue, 27 Jan 2026 20:49:00 GMT</pubDate>
<description>Proposed $1.0 million Convertible Debenture and concurrent $500,000 Private Placement Intended to Support Near-Term Operations Board and Management Enhancements Strengthen Governance and Capital Markets Execution Current Convertible Debenture Maturity Extended; Further Debt Optimization Planned VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel cancer therapie</description>
</item>
<item>
<title>Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-and-variational-ai-expand-collaboration-to-advance-next-generation-atr-inhibitors</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-and-variational-ai-expand-collaboration-to-advance-next-generation-atr-inhibitors</guid>
<pubDate>Thu, 08 Jan 2026 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V:...</description>
</item>
<item>
<title>Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-management-to-attend-partnering-meetings-during-jpm-week-january-in-san-francisco-california</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-management-to-attend-partnering-meetings-during-jpm-week-january-in-san-francisco-california</guid>
<pubDate>Wed, 17 Dec 2025 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V:...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Upcoming Webinar with Variational AI</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-upcoming-webinar-with-variational-ai</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-upcoming-webinar-with-variational-ai</guid>
<pubDate>Wed, 10 Dec 2025 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V:...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Three-Month Q3 ended September 30, 2025 Financial Results and Provides Corporate Update</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-three-month-q3-ended-september-30-2025-financial-results-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-three-month-q3-ended-september-30-2025-financial-results-and-provides-corporate-update</guid>
<pubDate>Mon, 01 Dec 2025 09:00:00 GMT</pubDate>
<description>All dollar amounts reflected in Canadian dollars ...</description>
</item>
<item>
<title>Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-debentureholder-approval-of-debenture-extension-expiry-of-warrant-incentive-program</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-announces-debentureholder-approval-of-debenture-extension-expiry-of-warrant-incentive-program</guid>
<pubDate>Sat, 29 Nov 2025 01:13:40 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics Inc. Announces Presentation of Second Abstract at the 2025 Society for Neuro-Oncology Annual Meeting</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-inc-announces-presentation-of-second-abstract-at-the-2025-society-for-neuro-oncology-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-inc-announces-presentation-of-second-abstract-at-the-2025-society-for-neuro-oncology-annual-meeting</guid>
<pubDate>Mon, 24 Nov 2025 11:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-showcases-compelling-preclinical-data-on-ai-discovered-cns-penetrant-atrmtor-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-showcases-compelling-preclinical-data-on-ai-discovered-cns-penetrant-atrmtor-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting</guid>
<pubDate>Mon, 24 Nov 2025 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-president-and-cso-to-present-and-join-expert-panel-at-the-9th-annual-ddr-inhibitors-summit-1</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-president-and-cso-to-present-and-join-expert-panel-at-the-9th-annual-ddr-inhibitors-summit-1</guid>
<pubDate>Tue, 18 Nov 2025 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its President and Chief Scientific Officer, Prof. Mads Daugaard, has been invited to present and participate as a panelist at the 9th Annual DNA Damage Response (DDR) Inhibitors Summit, taking place January 27–29, 2026, in Boston, MA. The DDR In</description>
</item>
<item>
<title>Rakovina Therapeutics' President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-president-and-cso-to-present-and-join-expert-panel-at-the-9th-annual-ddr-inhibitors-summit</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-president-and-cso-to-present-and-join-expert-panel-at-the-9th-annual-ddr-inhibitors-summit</guid>
<pubDate>Tue, 18 Nov 2025 09:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-highlighting-cns-penetrant-atr-and-parp1-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-highlighting-cns-penetrant-atr-and-parp1-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting</guid>
<pubDate>Mon, 10 Nov 2025 18:26:25 GMT</pubDate>
<description>VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-showcases-potent-ai-developed-atr-inhibitors-with-cns-penetrance-at-aacr-nci-eortc-international-conference</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-showcases-potent-ai-developed-atr-inhibitors-with-cns-penetrance-at-aacr-nci-eortc-international-conference</guid>
<pubDate>Mon, 27 Oct 2025 08:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-highlighting-novel-atr-inhibitor-with-cns-penetration-at-the-aacr-nci-eortc-international-conference</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-new-data-highlighting-novel-atr-inhibitor-with-cns-penetration-at-the-aacr-nci-eortc-international-conference</guid>
<pubDate>Thu, 16 Oct 2025 08:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x201...</description>
</item>
<item>
<title>Rakovina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference</title>
<link>https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-at-the-hc-wainwright-27th-annual-global-investment-conference</link>
<guid isPermaLink="true">https://6ix.com/company/rakovina-therapeutics-inc/news/rakovina-therapeutics-to-present-at-the-hc-wainwright-27th-annual-global-investment-conference</guid>
<pubDate>Thu, 04 Sep 2025 08:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (&#x20...</description>
</item>
</channel>
</rss>